Tiziana to Announce Six-Month Human Safety and Biomarker Data at the ECTRIMS Annual Congress, Following-Up from Positive Outcomes Data Presented in June
–News Direct– By Rachael Green, Benzinga Tiziana (Nasdaq: TLSA) is following-up with anticipated human data and announced the acceptance of a late-breaking poster at the 39th Congress of the European Committee for Treatment and Research…